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Ultrasound-guided fine-needle aspiration (FNA) cytology is the most widely used screening and 
diagnostic method for thyroid nodules. Although Western guidelines for managing thyroid nodules 
and the Bethesda System for Reporting Thyroid Cytopathology are widely available throughout 
Asia, the clinical practices in Asia vary from those of Western countries. Accordingly, the Working 
Group of Asian Thyroid FNA Cytology encouraged group members to publish their works jointly 
with the same topic. The articles in this special issue focused on the history of thyroid FNA, FNA 
performers and interpreters, training programs of cytopathologists and cytotechnicians, staining 
methods, the reporting system of thyroid FNA, quality assurance programs, ancillary testing, and 
literature review of their own country’s products. Herein, we provide a brief overview of thyroid 
FNA practices in China, India, Japan, Korea, the Philippines, Taiwan, and Thailand.
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Fine-needle aspiration (FNA) cytology has been widely accepted 
as a safe, cost-effective, and accurate tool for the preoperative 
diagnosis of thyroid nodules. In the past, aspirations were per-
formed only with the manual aid. Since FNA under ultrasound 
guidance proved to be more accurate for the detection of thyroid 
cancer, FNA should be performed under ultrasound guidance 
using a 23-, 25-, or 27-gauge needle for cytological evaluation.1,2 
The wide use of FNA cytology for thyroid nodules has significantly 
decreased the rate of unnecessary surgery for benign thyroid 
nodules over the last three decades.1,3 
Although North American and European guidelines for 
managing thyroid nodules and the Bethesda System for Reporting 
Thyroid Cytopathology (TBSRTC) are available throughout 
Asia, the clinical practices in Asia vary from those of Western 
countries in terms of disease incidence, diagnostic methods, 
availability of diagnostic tests, conservative management approach, 
national health insurance system, and governmental regulations 
on health care. Moreover, there is considerable variation among 
Asian countries due to the different rates of economic develop-
ment and kinds of healthcare systems. Asian countries have increas-
ingly reported their experiences of FNA of thyroid nodules using 
TBSRTC. Despite these efforts, Asian data on thyroid FNA have 
not been very well-organized so far. Accordingly, the Working 
Group of Asian Thyroid FNA Cytology established in 2016 has 
encouraged group members to publish their work jointly.4 
In this special issue, seven articles from China, India, Japan, 
Korea, the Philippines, Taiwan, and Thailand jointly focused 
on the same topic regarding the history of thyroid FNA, FNA 
performers and interpreters, the training programs of cytopa-
thologists and cytotechnicians, staining methods, the reporting 
system of thyroid FNA, quality assurance programs, and ancillary 
testing, added by the comprehensive review of publications released 
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from the individual countries.5-11 Herein, we provide a brief 
overview of contemporary thyroid FNA practices based on the 
review articles from seven Asian countries. 
HISTORICAL ASPECTS OF THYROID 
FINE-NEEDLE ASPIRATION 
In the late 1920s, Hayes Martin and Edward Ellis performed 
aspiration biopsies using an 18-gauge needle for the cytological 
evaluation of thyroid lesions in the Memorial Hospital of New 
York.12 In 1952, thyroid aspiration cytology using a fine needle 
(diameter of 0.4–0.8 mm) was introduced by Nils Söderström 
in Sweden.13 Thyroid FNA was used in routine practice as an 
accurate test for distinguishing between benign and malignant 
thyroid nodules in Sweden since the 1950s. In the United States, 
FNA was not successfully used for the diagnosis of thyroid nodules 
before 1970s because of the clinician’s preference for surgical 
biopsies, a lack of familiarity with the FNA procedure, and 
concerns about tumor seeding along the needle tract.14,15 After 
that time, thyroid FNA was reintroduced in the United States 
and became widely available in the 1980s.14
In Asia, thyroid FNA was introduced in China and Japan in 
the 1950s.9,10 In Korea, India, and Taiwan, thyroid FNA was 
introduced in the 1970s.5-7,11 Table 1 summarizes the brief history 
of thyroid FNA in seven Asian countries.5-11 
 
PERFORMERS AND INTERPRETERS 
OF THYROID FINE-NEEDLE 
ASPIRATION CYTOLOGY
Since thyroid FNA was initially introduced by clinicians in 
most countries, interpretation of FNA cytology were mostly 
done by clinicians in the past, including endocrinologists, surgeons, 
and radiologists. In recent years, thyroid FNA has been performed 
under ultrasound guidance by clinicians in Japan, Korea, the 
Philippines, Taiwan, and Thailand. Chinese clinicians prefer an 
intraoperative frozen section rather than FNA for the diagnosis 
of thyroid nodules.9 Thyroid FNA is more frequently performed 
through palpation rather than ultrasound in India, Thailand, and 
the Philippines because of limited or delayed access to sonography.5,8,11 
Table 2 summarizes the current practices of thyroid FNA per-
formers and interpreters in seven Asian countries.5-11 
STAINING METHODS OF THYROID 
FINE-NEEDLE ASPIRATION 
CYTOLOGY SAMPLES
The most widely used staining method for thyroid FNA 
specimens was Papanicolaou stain. Hematoxylin and eosin stain 
was favored by most Chinese pathologists.9 In India and Thailand, 
thyroid FNA samples were stained with a combination of two 
classical stains: alcohol-fixed smears were stained with Papani-
Table 2. Thyroid FNA performer and interpreter
Country Sampling Interpretation
China Primarily performed in endocrinology department in 1970–80s.
After 1987, thyroid FNA began to be popular in the pathology 
department.
Thyroid FNA is not yet well accepted in China.
Most general hospital use frozen section as a diagnostic method 
instead of thyroid FNA.
Primarily performed in endocrinology department in 1970–80s.
After 1987, thyroid FNA began to be interpreted mainly 
by pathologists.
India Blind, palpation-guided FNAs performed by cytopathologists
US-guided FNA performed by clinicians or radiologists
Palpation-guided FNA appears to be the most commonly 
used technique.
Interpretation done by pathologists
Rapid on-site evaluation done in few academic institutions
Japan US-guided FNA usually performed by clinicians Pathologists and clinicians with a board certification in cytopathology
Korea US-guided FNA usually performed by clinicians Pathologists (cytopathologists) only interpret the thyroid FNA.
Philippines Thyroid FNA procedure under US-guidance is performed 
by pathologists and clinicians.
Majority of pathologists report the diagnosis of cytology.
All interpretations are rendered by the pathologist.
Taiwan Radiologists are the major performer of thyroid FNA.
US is used in most cases.
Pathologists are the main diagnostician.
Before 1995, clinicians used to be both the performer and the 
interpreter of thyroid FNA.
Thailand FNA procedure is universally performed by clinicians.
In academic environment, trainees are frequently responsible 
to perform FNA.
Almost all cases of thyroid FNA cytology are signed out by certified 
pathologists.
Cytotechnologists are not involved in thyroid FNA.
Few endocrinologists sign out thyroid FNA in academic centers.
Rapid on-site evaluation is rarely performed.
FNA, fine-needle aspiration; US, ultrasound.
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.10.19
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colaou stain and air-dried smears were stained with modified 
Giemsa stain (e.g., May-Grünwald-Giemsa stain or Diff-Quik 
stain).5,8 Table 3 summarizes the staining methods for thyroid 
FNA cytology specimens.5-11 
REPORTING SYSTEM OF THYROID 
FINE-NEEDLE ASPIRATION CYTOLOGY
The reporting system of thyroid FNA cytology has improved 
significantly over the past 10 years with the introduction of 
TBSRTC.1,3 TBSRTC consists of six diagnostic categories in order 
to facilitate communication among cytopathologists and their 
clinical colleagues and to provide the risk of malignancy for 
each diagnostic category.3 After the introduction of TBSRTC, 
the system has been most widely accepted in China, India, Korea, 
the Philippines, and Thailand.5,6,8,9 Other reporting systems for 
thyroid FNA cytology used in Asia were the General Rules for 
the Description of Thyroid Cancer by the Japanese Society of 
Thyroid Surgery, the Japanese System for Thyroid FNA Cytology by 
the Japan Thyroid Association, and the 6-tier System of Taiwan.7,10 
Table 4 summarized the reporting system of thyroid FNA cytology 
before and after the introduction of TBSRTC.5-11 
NON-DIAGNOSTIC THYROID 
FINE-NEEDLE ASPIRATION 
Although ultrasound-guided thyroid FNA has high sensitivity 
and specificity in distinguishing benign from malignant thyroid 
nodules, in 1%–40% of cases, thyroid FNA is insufficient for 
diagnosis and is categorized as non-diagnostic according to 
TBSRTC.16 The non-diagnostic FNA cytology by TBSRTC 
includes virtually acellular specimens (requiring the presence of 
at least six groups of well-visualized follicular cells with each 
group containing at least 10 well-preserved epithelial cells), cystic 
fluid only, and other specimens (obscuring blood, crushed artifacts, 
poor clotting artifacts, air drying artifacts, overly thick smears, 
etc.).3 In the Japanese system, thyroid FNA with “cystic fluid 
only” is classified as benign rather than non-diagnostic.10,17 In 
Taiwan, a paucicellular specimen with fewer than six groups of 
ten benign follicular cells is considered benign if it contains 
more than 50 follicular cells in total or consists of degenerative 
hemorrhagic cyst fluid and scant benign follicular cells.7
Table 5 summarizes the criteria and rate of non-diagnostic 
thyroid FNA.5-11 A high rate of non-diagnostic aspirates was 
reported from several teaching hospitals in the Philippines and 
Thailand, which was linked to the training activity of unskilled 
residents and limited access to ultrasound guidance.8,11 
Table 3. Staining methods for thyroid fine-needle aspiration cytol-
ogy specimens
Country Staining method
China Wrights staining is popular in endocrine and clinical 
laboratory department.
H&E stain is common in pathology department.
India Combination of Romanowsky (May-Grünwald-Giemsa stain) 
and Papanicolaou stains is most widely used.
H&E stain in few institutions
Japan Papanicolaou stain is the most widely used.
Giemsa stain or Diff-Quik stain
Korea Papanicolaou stain is the most widely used.
H&E or Giemsa stain are used in some institutions.
Philippines Papanicolaou stain
Diff-Quik stain
H&E stain in cell blocks
Taiwan Papanicolaou stain
Liu stain
Thailand
Combination of Papanicolaou and Diff-Quik stains are 
most widely used.
H&E, hematoxylin and eosin.
Table 4. Reporting system of thyroid FNA cytology
Country Before TBSRTC After TBSRTC
China No data TBSRTC is the most widely accepted.
India No data TBSRTC is the most widely used.
Japan General Rules for the Description of Thyroid Cancer (GRDTC): 
adapted from the 1996 Papanicolaou Society 
recommendations; published by the Japanese Society 
of Thyroid Surgery in 2005 and updated in 2006
GRDTC system is widely used.
Japanese system for thyroid FNA cytology published by the Japan 
Thyroid Association (JTA) in 2013: used in several high-volume thyroid 
surgery centers
TBSRTC is rarely used.
Korea Not standardized and varied, but mostly followed guidelines 
of the Papanicolaou Society of Cytopathology
TBSRTC is the most widely accepted.
Philippines Based on histopathologic terminology of thyroid disorder TBSRTC is the most widely used.
Taiwan All investigators used different diagnostic categories. TBSRTC or the 6-tier system corresponding to each Bethesda category
Thailand Not standardized and varied, e.g., 
thyroid FNA reporting was based on specific diagnosis 
of the lesions.
TBSRTC is the most widely accepted.
FNA, fine-needle aspiration; TBSRTC, The Bethesda System for Reporting Thyroid Cytopathology.
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LIQUID-BASED CYTOLOGY 
AND ANCILLARY TESTS
In Korea, the use of liquid-based cytology in thyroid FNA 
was adopted in 2008 and became widely used since 2010.6,18 In 
Taiwan, liquid-based cytology in thyroid FNA was first introduced 
in 2014 and then became commonly used.7 However, liquid-
based cytology has not been made widely available for thyroid 
FNA in other countries.5,8-11
Core needle biopsy as an alternative to thyroid FNA has been 
used mainly in Korea whereas in other countries, this biopsy is 
performed only in a few institutions.5-10 
Immunocytochemistry generally has limited applications for 
the diagnosis of thyroid FNA in Asian countries. Although 
molecular testing has been useful for the diagnosis of indeter-
minate thyroid FNA, it is often not practical for most clinical 
laboratories and is generally not covered by health insurance in 
Asia.5-11
Table 6 summarizes the ancillary tests in thyroid FNA cytology.5-11 
 
Table 5. Non-diagnostic thyroid FNA
Country Criteria for non-diagnostic FNA Incidence of non-diagnostic FNA
China TBSRTC 3.6% at one institution
India TBSRTC
Different criteria in a study: 10 clusters are needed with each having more than 20 cells; 
in case of presence of tissue fragments, minimum number of fragments required is 8.
Royal College of Pathologists guidelines in one study
7.4% (0.5%–25.7%) from 38 studies
Japan General Rules for the Description of Thyroid Cancer system
Japanese system
10% according to the Japanese system
Korea TBSRTC 12.4% (0%–32.6%) from 12 institutions
Philippines TBRSTC 1.3% and 23.1% from 2 studies
Taiwan Variable but different from TBRSTCa 8% at one institution
Thailand TBSRTC 12.7%–47.6% from three institutions
FNA, fine-needle aspiration; TBSRTC, the Bethesda System for Reporting Thyroid Cytopathology.
aMost Taiwan pathologists consider that the specimen is negative, but not non-diagnostic when there are less than six groups but more than 50 follicular cells 
in total or a degenerative hemorrhagic cyst with scant benign follicular cells.
Table 6. Ancillary tests in thyroid FNA cytology
Country Liquid-based cytology Core needle biopsy Immunocytochemistry Molecular or other testing
China Not commonly used No data No data Amplification refractory mutation system 
for BRAF V600E is the most popular 
technique.
Next generation sequencing is not well 
accepted.
India Has been used in some 
institutions as addition 
to conventional smears
Limited applicability and 
acceptability
Limited applicability and 
acceptability
Limited applicability and acceptability
Japan Used in some laboratories, 
but is not widely available
Rarely performed No data BRAF testing is uncommon practice and 
not covered by national health insurance 
system.
Thyroglobulin and/or calcitonin in FNA 
needle washings is often used in thyroid 
or lymph node aspirates.
Korea Became popular since 
2010
Used in 68% institutions 
in 2016
Widely used Not routinely used but can be 
applied in specific cases
BRAF testing is used.
Thyroglobulin and/or calcitonin in FNA 
needle washings is often used in thyroid 
or lymph node aspirates.
Philippines Not used No data Rarely performed Not covered by health care insurance
Referred to outsource/abroad facilities 
if patients agree to pay
Taiwan Became popular since 
2014
Rarely performed In some institutions, 
immunocytochemical staining 
is used.
In some institutions, molecular testing 
is used.
Thailand Rarely used Very uncommon Available, but rarely performed Rarely used due to limited availability
FNA, fine-needle aspiration.
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TRAINING PROGRAM
Asian pathologists receive a certification in pathology and cyto-
pathology after completing residency training and passing 
board examinations, and usually practice both surgical pathology 
and cytopathology. Training programs for cytotechnicians have 
been well organized in Japan, Korea, and Taiwan. Certified cyto-
technicians screen thyroid FNA cytology, but are not eligible to 
declare a final diagnosis without supervision by a pathologist. 
Table 7 summarizes the training programs for cytopathologists 
and cytotechnicians.5-11 
QUALITY CONTROL AND QUALITY 
ASSURANCE PRACTICES
Quality control in cytology includes all activities to improve 
the performance of the test from the time of specimen collection 
until the cytology report is completed. Quality assurance defined 
by the College of American Pathologists includes quality review 
activities and systematic monitoring of quality control results 
to provide confidence that all quality control systems are func-
tioning properly and quality requirements are fulfilled.19 Quality 
control materials in thyroid FNA should include the distribu-
tion of each diagnostic category, histologic outcomes of FNA 
diagnostic categories, rate of surgical follow-up, and risk of 
malignancy calculated using the total number of each diagnostic 
category with and without surgical follow-up.
Quality improvement programs in Asian countries are orga-
nized by local societies of cytology and/or pathology. Table 8 
summarizes the quality assurance and quality control programs 
in thyroid FNA cytology.5-11 
CONCLUSION
The purpose of the recently established Working Group of 
Asian Thyroid FNA Cytology is to promote communication 
and share practices among pathologists, cytopathologists, and 
clinicians dealing with thyroid FNA in Asia. In this special issue, 
we presented for the first time a single volume collection of con-
temporary reviews on Asian practices of thyroid FNA. Despite 
Table 7. Training programs for cytopathologists and cytotechnicians
Country Cytopathologist Cytotechnician
China No data No data
India No data Indian Academy of Cytologists conducts exam for cytotechnicians and 
cytotechnologists.
Few centers run cytotechnician and cytotechnologist training programs 
for certification.
Only limited institutions have cytoscreeners.
Japan Pathologists have dual boards of anatomical pathology 
and cytopathology.
Clinicians also have board of cytopathology.
JSCC certification
Candidate 1: medical technologist after 3-year course at a vocational 
school or 4-year course at a medical technology school, 1-year work 
experience requirements at the cytology laboratory of a teaching hospital
Candidate 2: 4-year college graduate 
Korea Pathology residents must pass the exam in both fields 
of surgical pathology and cytolopathology to get 
the pathology board.
For board certificated pathologists, there is annual 
requirement for continuing cytology education activities.
Nationwide cytotechnician education program began under the auspices 
of the World Health Organization in 1981.
After 2-year pathology or cytology laboratory practice as a technician, 
1-year training program at a National Cancer Center and 
certification exam
Philippines Formal cytopathology training programs are not offered.
Conferences in cytopathology are embedded 
in the training program of anatomic pathology.
No training programs
Taiwan At least 3 months of cytology screening and sign-out 
practice
Pathology residents are required to attend a 2-week 
intensive course.
Pathology residents should pass both exams of 
surgical pathology and cytolopathology to get 
the pathology board.
For board certificated pathologists, there is annual 
requirement for continuing cytology education 
activities.
One-year on-site training at a qualified training institution and a final exam
There are 12 qualified institutions for cytotechnologist training in Taiwan.
Thailand General cytopathology and thyroid cytology are the 
essential parts of the training program for anatomic 
pathology residents.
No data
JSCC, Japanese Society of Clinical Cytology.
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Table 8. Quality assurance and quality control programs in thyroid FNA cytology
Country Internal program Nationwide external program
China No data No data
India No data External Quality Assurance Programme of the Indian Academy 
of Cytologists
Only straightforward diagnose are assessed for thyroid FNA quality 
control.
Japan No data No data
Korea Accuracy assessment by cyto-histological correlations
Annual reports on quality control of thyroid FNA 
have been published since 1996.
Cytology proficiency testing in the Korean Society for Cytopathology 
has been performed since 1996.
National quality control program in the Korean Society of Pathologists 
began in 1999.
Philippines Self-review
Intradepartmental referral to another pathologist
All thyroid surgeries with previous FNA done in the same 
hospital are reviewed.
In the process of developing an external quality assurance program 
in cytopathology
Taiwan No data Currently there is no authoritative quality assurance program 
for external evaluation.
Thailand No data External quality assurance program for Thai pathologists is set up and 
supported by the Thai Society of Cytology.
No nationwide thyroid FNA cytologic-histological correlation program
FNA, fine-needle aspiration.
most countries adopting Western systems and guidelines and 
incorporated them into their national systems early, there remains 
local variation which should be considered when doing compari-
sons between Asian and Western countries, and among Asian 
countries. We hope that these reports from Asia will encourage 
further studies on thyroid FNA cytology to improve the diag-
nosis of thyroid nodules and subsequently provide optimal care 
for patients with thyroid nodules in Asia. 
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